[
  {
    "ts": null,
    "headline": "Charles River Laboratories International (CRL) Expands Oncology Partnerships With PICI and CHLA",
    "summary": "Charles River Laboratories International (CRL) recently announced strategic collaborations to advance oncology research. This news comes amid a 2.91% price increase over the past month. During this period, the broader market, including major indexes like the S&P 500, rose to record highs, bolstered by inflation data indicating potential interest rate cuts by the Federal Reserve. While these macroeconomic factors likely influenced CRL's share price positively, the company's efforts in oncology...",
    "url": "https://finnhub.io/api/news?id=585ff8f46aef63cf4b8509dc874939ade3ce505aed02fa497ee37cc38f4be67e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757615381,
      "headline": "Charles River Laboratories International (CRL) Expands Oncology Partnerships With PICI and CHLA",
      "id": 136704759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River Laboratories International (CRL) recently announced strategic collaborations to advance oncology research. This news comes amid a 2.91% price increase over the past month. During this period, the broader market, including major indexes like the S&P 500, rose to record highs, bolstered by inflation data indicating potential interest rate cuts by the Federal Reserve. While these macroeconomic factors likely influenced CRL's share price positively, the company's efforts in oncology...",
      "url": "https://finnhub.io/api/news?id=585ff8f46aef63cf4b8509dc874939ade3ce505aed02fa497ee37cc38f4be67e"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer",
    "summary": "WILMINGTON, Mass., September 11, 2025--Charles River collaborates to enhance oncology manufacturing portfolio by advancing development of cell and gene therapies to treat cancer.",
    "url": "https://finnhub.io/api/news?id=ebb45227c27013084cc78bca8adfe1c62b1c8eb64aefdb16f4c8905f3393b326",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757595600,
      "headline": "Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer",
      "id": 136704760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., September 11, 2025--Charles River collaborates to enhance oncology manufacturing portfolio by advancing development of cell and gene therapies to treat cancer.",
      "url": "https://finnhub.io/api/news?id=ebb45227c27013084cc78bca8adfe1c62b1c8eb64aefdb16f4c8905f3393b326"
    }
  },
  {
    "ts": null,
    "headline": "3 Unpopular Stocks That Concern Us",
    "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
    "url": "https://finnhub.io/api/news?id=527d6a885d5ed45e7abbd3da98972049fc3379b003a0db54c826914a573070b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757568954,
      "headline": "3 Unpopular Stocks That Concern Us",
      "id": 136704761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
      "url": "https://finnhub.io/api/news?id=527d6a885d5ed45e7abbd3da98972049fc3379b003a0db54c826914a573070b6"
    }
  }
]